» Articles » PMID: 32346504

Leveraging a Bayesian Network Approach to Model and Analyze Supplier Vulnerability to Severe Weather Risk: A Case Study of the U.S. Pharmaceutical Supply Chain Following Hurricane Maria

Overview
Date 2020 Apr 30
PMID 32346504
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The United States government has identified the health care sector as part of the critical infrastructure for homeland security to protect citizens against health risks arising from terrorism, natural disasters, and epidemics. Citizens also have expectations about the role that health care plays in enjoying a good quality of life, by providing response systems to handle emergencies and other illness situations adequately. Among the systems required to supportdesired performance levels is a robust and resilient pharmaceutical supply chain that is free of disruption. Shortages of drugs place undue pressure on healthcare providers to devise alternative approaches to administer patient care. With climate change expected to result in increasingly severe weather patterns in the future, it is critical that logistics engineers understand the impact that a catastrophic weather event could have on supply chain disruption to facilitate the design of supply systems that are robust and resilient. This study investigates the main causal and intermediate events that led to risk propagation in, and disruption of, the U.S. pharmaceutical supply chain following Hurricane Maria. A causality Bayesian model is developed to depict linkages between risk events and quantify the associated cumulative risk. The quantification is further examined through different advanced techniques such as predictive inference reasoning and sensitivity analysis. The general interpretation of these analyses suggests that port resilience is imperative to pharmaceutical supply chain performance in the case of Puerto Rico.

Citing Articles

Assessing the Disruption Impact on Healthcare Delivery.

Fatani M, Shamayleh A, Alshraideh H J Prim Care Community Health. 2024; 15:21501319241260351.

PMID: 38907592 PMC: 11193933. DOI: 10.1177/21501319241260351.


Analysis of Pharmaceutical Demand in the Region for Chronic Medicine Users Using National Health Insurance Data: Examination for Disaster Preparedness in Hakui City, Ishikawa Prefecture.

Moriwaki Y, Morisaki Y, Karashima S, Fujiu M Healthcare (Basel). 2023; 11(23).

PMID: 38063597 PMC: 10871114. DOI: 10.3390/healthcare11233029.


Data quality in an HIV vaccine efficacy clinical trial in South Africa: through natural disasters and with discipline.

Laher F, Malahleha M, Ramirez S, Brumskine W, Otwombe K, Moodie Z BMC Med Res Methodol. 2023; 23(1):147.

PMID: 37355583 PMC: 10290289. DOI: 10.1186/s12874-023-01967-9.


Impact of Social Forces and Environmental Factors on Healthcare and Pharmacy Education: The Report of the 2021-2022 AACP Argus Commission.

DiPiro J, Allen D, Lin A, Scott S, Sorensen T, Maine L Am J Pharm Educ. 2023; 87(1):ajpe9452.

PMID: 36781186 PMC: 10159613. DOI: 10.5688/ajpe9452.


Research on Co-Opetition Mechanism between Pharmaceutical Enterprises and Third-Party Logistics in Drug Distribution of Medical Community.

Li Z, Xia T, Shen W, Chen S Int J Environ Res Public Health. 2023; 20(1).

PMID: 36612930 PMC: 9819418. DOI: 10.3390/ijerph20010609.


References
1.
Mazer-Amirshahi M, Fox E . Saline Shortages - Many Causes, No Simple Solution. N Engl J Med. 2018; 378(16):1472-1474. DOI: 10.1056/NEJMp1800347. View

2.
Friedman N, Linial M, Nachman I, Peer D . Using Bayesian networks to analyze expression data. J Comput Biol. 2000; 7(3-4):601-20. DOI: 10.1089/106652700750050961. View

3.
Neil M, Fenton N, Lagnado D, Gill R . Modelling competing legal arguments using Bayesian model comparison and averaging. Artif Intell Law (Dordr). 2020; 27(4):403-430. PMC: 7114955. DOI: 10.1007/s10506-019-09250-3. View

4.
Schafer J, Strimmer K . An empirical Bayes approach to inferring large-scale gene association networks. Bioinformatics. 2004; 21(6):754-64. DOI: 10.1093/bioinformatics/bti062. View

5.
Mehralian G, Rajabzadeh Gatari A, Morakabati M, Vatanpour H . Developing a suitable model for supplier selection based on supply chain risks: an empirical study from Iranian pharmaceutical companies. Iran J Pharm Res. 2013; 11(1):209-19. PMC: 3813095. View